In this article, we discuss the 10 most shorted stocks to watch in July.
Keep Reading →
July 19 - Hedge Funds, News - Comments
In this article, we will discuss 15 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
Keep Reading →
September 29 - Hedge Funds, News - Comments
In this article, we discuss the 5 best short squeeze stocks to buy now.
Keep Reading →
September 25 - Hedge Funds, News - Comments
Billionaire investor Bill Ackman said Monday he donated his entire stake in Coupang - worth more than $1 billion - to charity following the South Korean e-commerce company’s...
Keep Reading →
March 15 - Hedge Funds, Insider Trading - Comments
In this article we discuss top 5 underperforming stocks targeted by short sellers.
Keep Reading →
February 1 - Hedge Funds, News - Comments
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period.
Keep Reading →
December 19 - Hedge Funds, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file ...
Keep Reading →
October 6 - Hedge Funds, News - Comments
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Keep Reading →
August 4 - Hedge Funds, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
June 23 - Hedge Funds, News - Comments
We hate to say this but, we told you so.
Keep Reading →
March 28 - Hedge Funds, News - Comments
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Keep Reading →
December 8 - Hedge Funds, News - Comments
Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in...
Keep Reading →
October 23 - Hedge Funds, News - Comments
Of all the billionaires, hedge fund managers and chief executives who have showered politicians in New York with money in the last five years, no one has given more often than...
Keep Reading →
August 26 - Hedge Funds, Insider Trading - Comments
"The end to the U.S. Government shutdown, reports of progress on China-U.S.
Keep Reading →
June 13 - Hedge Funds, News - Comments
While the market driven by short-term sentiment influenced by uncertainty regarding the future of the interest rate environment in the US, declining oil prices and the trade war...
Keep Reading →
April 26 - Hedge Funds, News - Comments
Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips.
Keep Reading →
December 17 - Hedge Funds, News - Comments
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Keep Reading →
December 5 - Hedge Funds, News - Comments
In contrast to yesterday's action, the major indexes are all green today, with crude futures leading the way, up by 5%.
Keep Reading →
April 8 - Market Movers, News - Comments
This week's roller coaster is coming to and end with a bang, as U.S. stocks are deep in the red territory and the Dow is down by triple digits.
Keep Reading →
December 18 - Market Movers, News, Tech - Comments
Seeing as all three indexes have surged more than 1% in morning trading as the Federal Reserve promises interest rates will still be low for a while, shares of Inland Real Estate...
Keep Reading →
December 15 - News - Comments
After several tireless days we have finished crunching the numbers from the more than 700 13F filings issued by the elite hedge funds and other investment firms that we track ...
Keep Reading →
November 23 - Hedge Funds, News - Comments
Cheyne Capital is one of the few non-U.S firms that we track in our database.
Keep Reading →
October 21 - Hedge Fund Analysis, Hedge Funds, News - Comments
Stocks in the biotechnology industry have been very active as of late, with companies' shares registering significant gains.
Keep Reading →
March 31 - Hedge Funds, News - Comments
According to a Schedule 13D form filed yesterday with the Securities and Exchange Commission, Samuel Islay's Orbimed Advisors has slashed its stake in Intercept Pharmaceuticals...
Keep Reading →
March 26 - Hedge Funds, News - Comments
Steve Cohen’s Point72 Asset Management disclosed today a new position in Applied Genetic Technologies Corp (NASDAQ:AGTC). The funds affiliated with Mr.
Keep Reading →
October 7 - Hedge Funds, News - Comments
Orbimed Advisors, led by Samuel Isaly, recently published its 13F filing with the U.S. Securities and Exchange Commission.
Keep Reading →
August 28 - Hedge Funds, News - Comments
Orbimed Advisors, led by Samuel Isaly, has disclosed cutting its position in Intercept Pharmaceuticals Inc. (NASDAQ:ICPT).
Keep Reading →
August 28 - Hedge Funds, News - Comments
Intercept Pharmaceuticals Inc.
Keep Reading →
August 12 - News - Comments
After being a dominant player in the hepatitis C market with its drug Sovaldi, Gilead Sciences, Inc.
Keep Reading →
July 18 - News - Comments
Small-cap picks from individual funds might provide investors with attractive investment options.
Keep Reading →
June 26 - Hedge Funds, News - Comments
Orbimed Advisors is limiting exposure to Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after selling approximately 81,305 shares in one transaction at $320 a piece, according...
Keep Reading →
April 14 - Hedge Funds, News - Comments
In another set of filing with the Securities and Exchange Commission, Steven Cohen and his fund, SAC Capital Advisors, have revealed a number of changes to their equity portfolio...
Keep Reading →
April 4 - Hedge Funds, News - Comments
Jacob Gottlieb's Visium Asset Management has increased its stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), according to an amended filing with the SEC. Gottlieb's fund...
Keep Reading →
January 10 - Hedge Funds, News - Comments
Steve Cohen's SAC Capital has just revealed a 5.3% stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), a new filing with the SEC indicates.
Keep Reading →
November 8 - Hedge Funds, News - Comments
Orbimed Advisors, Intercept Pharmaceuticals: Samuel Isaly and his hedge fund, Orbimed Advisors, is focused on healthcare stocks.
Keep Reading →
October 24 - Hedge Funds, News - Comments
Orbimed Advisors, Intercept Pharmaceuticals: In a recent SEC filing, Samuel Isaly and his hedge fund, Orbimed Advisors, reported decreasing their holding in Intercept Pharmaceuticals...
Keep Reading →
October 18 - Hedge Funds, News - Comments
To the average investor, there are many methods market participants can use to analyze publicly traded companies.
Keep Reading →
September 17 - News - Comments
To the average investor, there are tons of methods market participants can use to track publicly traded companies.
Keep Reading →
September 13 - News - Comments
In the financial world, there are dozens of indicators investors can use to track publicly traded companies. Two of the best are hedge fund and insider trading movement.
Keep Reading →
September 4 - News - Comments
At the moment, there are tons of indicators shareholders can use to analyze publicly traded companies.
Keep Reading →
September 3 - News - Comments
In the eyes of many investors, hedge funds are seen as useless, outdated investment tools of a forgotten age.
Keep Reading →
August 30 - News - Comments
To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies.
Keep Reading →
August 26 - News - Comments
While the market jittered this week over what the Federal Reserve will do next, some stocks didn't flinch.
Keep Reading →
June 24 - News - Comments
At the moment, there are plenty of metrics shareholders can use to watch Mr. Market. A pair of the best are hedge fund and insider trading activity.
Keep Reading →
June 17 - News - Comments
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) was in 10 hedge funds' portfolio at the end of March.
Keep Reading →
June 14 - News - Comments
Is Pacira Pharmaceuticals Inc (NASDAQ:PCRX) a superb investment right now? Hedge funds are in an optimistic mood.
Keep Reading →
June 12 - News - Comments
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was in 16 hedge funds' portfolio at the end of the first quarter of 2013.
Keep Reading →
June 6 - News - Comments
According to most shareholders, hedge funds are seen as unimportant, outdated investment vehicles of years past.
Keep Reading →
June 4 - News - Comments
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was in 14 hedge funds' portfolio at the end of the fourth quarter of 2012.
Keep Reading →
April 10 - News - Comments
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was in 14 hedge funds' portfolio at the end of December.
Keep Reading →
April 10 - News - Comments